Use of flash glucose monitoring system in assessing safety of the SGLT2 inhibitors during Ramadan fasting in high risk insulin treated patients with type 2 diabetes

Abdelgadir, Elamin; Rashid, Fouzia; Bashier, Alaaeldin; Saeed, Muhammad; Khalifa, A.; Alawadi, Fatheya; Hassanein, Mohamed

doi:10.1016/j.dsx.2019.07.055

Cited by 21 publications

(32 citation statements)

References 26 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…The incremental benefits are similar to those reported in the studies using structured NT delivered during the non-Ramadan period [7][8][9]. Although the reduction in HbA1c by 0.72% in sRNT group was not significantly different from the SC group (−0.35%), it was much higher than previously reported by Ramadan-focused education studies, where it ranged from 0.2%-0.4% among patients with T2D [10][11][12][13][14]. The improvement in HbA1c was unlikely due to medication or weight loss as both parameters remained unchanged throughout Ramadan.…”

Section: Discussionsupporting

confidence: 85%

“…The optimal administration of structured NT regimen during Ramadan fasting remains unclear. Many studies have reported the benefits of providing Ramadan-focused intervention [4,[10][11][12][13][14]. Nonetheless, none of these studies have explored the potential of structured NT, including the use of DSF in patients' diets during Ramadan fasting.…”

Section: Introductionmentioning

confidence: 99%

See 1 more Smart Citation

Comparison of Structured Nutrition Therapy for Ramadan with Standard Care in Type 2 Diabetes Patients

et al. 2020

View full text Add to dashboard Cite

1) Background: Structured nutrition therapy (NT) is essential for the management of type 2 diabetes (T2D), but the optimal delivery during Ramadan fasting remains unclear. The present study aimed to evaluate the effect of structured NT program versus standard care in patients with T2D during Ramadan.(2) Methods: The present study was an 8-week, parallel, non-randomized study with patients' preference design involving 64 patients with T2D. The participants were asked to choose their preferred group, i.e., structured NT (Structured Ramadan NT, sRNT) or standard care (SC). The participants in the sRNT group received a Ramadan-focused nutrition plan, including a diabetes-specific formula throughout the study, whereas the patients in the SC group received standard nutrition care. Study outcomes included clinical outcomes and quality of life (QoL). Data was analyzed using two-way repeated-measures ANOVA and linear mixed-effects model. (3) Results: More than half of the participants (n = 38, 63%) chose sRNT as their preferred group. Both groups had comparable baseline characteristics. After 8-weeks of the respective intervention, participants in the sRNT group had lower levels of fasting plasma glucose (−0.9 ± 0.3 mmol/L vs. 0.2 ± 0.3 mmol/L, p < 0.05), triglycerides (−0.21 ± 0.08 mmol/L vs. 0.20 ± 0.17 mmol/L, p < 0.05), and self-monitoring glucose at pre-dawn (6.9 mmol/L vs. 7.8 mmol/L, p < 0.05) and pre-bedtime (7.6 mmol/L vs. 8.6 mmol/L, p < 0.05) than participants in the SC group. Although not different between groups, HbA1c levels decreased significantly in the sRNT (−0.72 ± 0.16%, p < 0.001) but not in the SC group (−0.35 ± 0.24%, p = 0.155). QoL and satisfaction scores improved significantly in sRNT group, but not in SC group.(4) Conclusions: The structured NT regimen for Ramadan is a feasible and beneficial program for T2D patients observing Ramadan fasting as it showed an improvement in clinical outcomes and QoL.

show abstract

Section: Discussionsupporting

confidence: 85%

Section: Introductionmentioning

confidence: 99%

Comparison of Structured Nutrition Therapy for Ramadan with Standard Care in Type 2 Diabetes Patients

et al. 2020

View full text Add to dashboard Cite

show abstract

“…Three studies (5,17,24) in 239 participants showed no significant effect on SBP (mmHg) (SMD -1.10, 95% CI -6.13 to 3.94) and DBP (mmHg) (SMD -2.08, 95% CI -3.42 to -0.73). The heterogeneity of the outcomes for SBP was I 2 = 59% and for DBP I 2 = 37%.…”

Section: Ramadan C Blood Pressurementioning

confidence: 93%

“…Singapore (17), France (18), United Kingdom (19)(20)(21)(22), Qatar (23), United Arab Emirates (24,25), Egypt (26), Lebanon (27) and Pakistan (28). Several multi-center studies were included in this review (29)(30)(31)(32)(33)(34)(35)(36)(37)(38)(39)(40)(41).…”

Section: Study Characteristicsmentioning

confidence: 99%

“…Several multi-center studies were included in this review (29)(30)(31)(32)(33)(34)(35)(36)(37)(38)(39)(40)(41). Eight studies were randomized controlled trials (15,16,19,27,29,34,38,39) Five studies reported on hospital admissions during Ramadan (15,18,24,31,37), but were not included in the meta-analysis due to different methods of outcome reporting. One study reported on the number of cases with DKA and medication adherence at two time points (37), but was not eligible as recommended by the Cochrane group, the meta-analysis should combine results from two or more separate studies (10).…”

Section: Study Characteristicsmentioning

confidence: 99%

See 1 more Smart Citation

Efficacy and safety of the newer oral hypoglycemic agents in patients with T2DM during Ramadan: A systematic review and meta-analysis

Gad

Hayat

Almuhannadi

et al. 2021

Diabetes Research and Clinical Practice

View full text Add to dashboard Cite

This is a PDF file of an article that has undergone enhancements after acceptance, such as the addition of a cover page and metadata, and formatting for readability, but it is not yet the definitive version of record. This version will undergo additional copyediting, typesetting and review before it is published in its final form, but we are providing this version to give early visibility of the article. Please note that, during the production process, errors may be discovered which could affect the content, and all legal disclaimers that apply to the journal pertain.

show abstract

Safety and effectiveness of newer antidiabetic medications during Ramadan fasting and safety of Ramadan fasting after bariatric surgery

Ahmed

Badi

Elidrisi

et al. 2022

J Diabetes Metab Disord

View full text Add to dashboard Cite

Use of flash glucose monitoring system in assessing safety of the SGLT2 inhibitors during Ramadan fasting in high risk insulin treated patients with type 2 diabetes

Cited by 21 publications

References 26 publications

Comparison of Structured Nutrition Therapy for Ramadan with Standard Care in Type 2 Diabetes Patients

Comparison of Structured Nutrition Therapy for Ramadan with Standard Care in Type 2 Diabetes Patients

Efficacy and safety of the newer oral hypoglycemic agents in patients with T2DM during Ramadan: A systematic review and meta-analysis

Safety and effectiveness of newer antidiabetic medications during Ramadan fasting and safety of Ramadan fasting after bariatric surgery

Contact Info

Product

Resources

About